Qube Research & Technologies Ltd - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 50 filers reported holding OMEGA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$221,554
+82.0%
36,742
+72.3%
0.00%0.0%
Q4 2022$121,743
+93.2%
21,321
+83.5%
0.00%
Q3 2022$63,000
+21.2%
11,618
-14.7%
0.00%
Q2 2022$52,00013,6190.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 352,941$6,653,0008.31%
CHI Advisors LLC 1,055,882$19,904,0005.81%
Flagship Pioneering Inc. 25,902,269$488,258,0005.11%
HARBOURVEST PARTNERS LLC 2,647,059$49,897,0004.69%
Octagon Capital Advisors LP 370,279$6,980,0001.72%
Monashee Investment Management LLC 441,176$8,316,0001.54%
Artal Group S.A. 2,273,530$42,856,0000.96%
SPHERA FUNDS MANAGEMENT LTD. 527,948$9,952,0000.84%
PLATINUM INVESTMENT MANAGEMENT LTD 500,000$9,425,0000.26%
Logos Global Management LP 88,235$1,663,0000.12%
View complete list of OMEGA THERAPEUTICS INC shareholders